Cyclic AMP
Research stageAlso known as 3',5'-cyclic AMP, AMPC, Cyclic adenylic acid, cAMP+7 more
3',5'-cyclic AMP, AMPC, Cyclic adenylic acid, cAMP, ADENOSINE CYCLIC 3',5'-PHOSPHATE, ADENOSINE CYCLIC PHOSPHATE, Adenosine 3',5'-cyclic monophosphate, Adenosine 3',5'-cyclic phosphate, Adenosine 3',5'-phosphate, Cyclic adenosine monophosphate, cAMP - Cyclic adenosine monophosphate.
Recent clinical, regulatory, research and industry developments relating to this drug.
Hippocampal Commissural Circuitry Shows Asymmetric cAMP-Dependent Synaptic Plasticity.
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment.
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function.
The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB.
cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- ACS chemical neuroscience1
- Cell reports1
- Diabetes1
- Frontiers in immunology1
- Genes & development1
- International journal of molecular sciences1
- Alatzoglou D1
- Altsman VL1
- Breustedt J1
- Bühler L1
- Canettieri G1
- Caux C1
- Chen J1
- Coukos G1
- University of Lausanne2
- Bernstein Center for Computational Neuroscience1
- Cancer Center1
- Columbia University1
- German Center for Neurodegenerative Diseases (DZNE)1
- Institute of Cell Biology and Neurobiology1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 6 of the same disease areas as Cyclic AMP in the shared literature.
Studied across 5 of the same disease areas as Cyclic AMP in the shared literature.
Studied across 4 of the same disease areas as Cyclic AMP in the shared literature.
Studied across 3 of the same disease areas as Cyclic AMP in the shared literature.
Studied across 2 of the same disease areas as Cyclic AMP in the shared literature.
Studied across 2 of the same disease areas as Cyclic AMP in the shared literature.
Studied across the same disease area as Cyclic AMP in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature